Zevra therapeutics to report first quarter 2024 results on may 8, 2024

Celebration, fla., may 01, 2024 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra, or the company), a rare disease therapeutics company, today announced that it will host a conference call and audio webcast on wednesday, may 8, 2024, at 8:00 a.m. et, to review its corporate and financial results for the first quarter of 2024.
ZVRA Ratings Summary
ZVRA Quant Ranking